首页> 外国专利> Specific antibody against human haemoglobin A-1c - used for quantitative determination of haemoglobin A-1c levels in diabetics by radioimmunological assay

Specific antibody against human haemoglobin A-1c - used for quantitative determination of haemoglobin A-1c levels in diabetics by radioimmunological assay

机译:抗人血红蛋白A-1c的特异性抗体-用于通过放射免疫法定量测定糖尿病患者的血红蛋白A-1c水平

摘要

A novel antibody, (I) against human haemoglobin A1c is essentially free from cross-reactions towards the human haemoglobins Ao, A1a and A1b. The quantitative determn. of haemoglobin A1c in a blood sample comprises treating the sample with (I) and then detecting the antigen/antibody complex by radio-immunology. The blood level of haemoglobin A1c in diabetics is higher than in healthy people. The determn. of haemoglobin A1c levels is used to evaluate new drugs and in the therapy and research of the general pathophysiology of diabetes. Quantitative determn. of haemoglobin A1c is used in the investigation of carbohydrate tolerance. The method of haemoglobin A1c determination allows one person to carry out 30-40 tests in one day in a shorter time than was previously required for 2 or 3 tests. (I) is highly specific towards haemoglobin A1c as an antigen, even in the presence of other, very similar antigens. The method is suitable for evaluation of haemoglobin levels over 6%.
机译:针对人血红蛋白A1c的新型抗体(I)基本上没有与人血红蛋白Ao,A1a和A1b的交叉反应。定量确定。血液样品中血红蛋白A1c的测定包括用(I)处理样品,然后通过放射免疫学检测抗原/抗体复合物。糖尿病患者的血红蛋白A1c水平高于健康人。确定。血红蛋白A1c水平的评估被用于评估新药以及糖尿病的一般病理生理学的治疗和研究。定量测定。的血红蛋白A1c用于研究糖耐量。血红蛋白A1c的测定方法使一个人可以在一天之内完成30-40个测试,所需的时间比以前进行2或3个测试所需的时间短。 (I)对血红蛋白A1c作为抗原具有高度特异性,即使在存在其他非常相似的抗原的情况下也是如此。该方法适用于评估超过6%的血红蛋白水平。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号